{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:47:49Z","timestamp":1792640869950,"version":"4.5.0"},"reference-count":220,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T00:00:00Z","timestamp":1795046400000},"content-version":"am","delay-in-days":383,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1I01BX006018"],"award-info":[{"award-number":["1I01BX006018"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH107615"],"award-info":[{"award-number":["MH107615"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuron"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuron.2025.09.010","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:14:50Z","timestamp":1759990490000},"page":"3722-3740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Synaptic priming: A framework for pharmacotherapy in depression"],"prefix":"10.1016","volume":"113","author":[{"given":"Kyle A.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa I.","family":"Ajibola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo C.","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1511-7183","authenticated-orcid":false,"given":"Todd D.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuron.2025.09.010_bib1","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib2","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41380-018-0256-5","article-title":"Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)","volume":"25","author":"Fava","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial","volume":"75","author":"Daly","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib6","series-title":"Mental Disorders","year":"2022"},{"key":"10.1016\/j.neuron.2025.09.010_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpsychires.2024.07.054","article-title":"Change in the global burden of depression from 1990\u20132019 and its prediction for 2030","volume":"178","author":"Zhang","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuron.2025.09.010_bib8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40273-021-01019-4","article-title":"The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018)","volume":"39","author":"Greenberg","year":"2021","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.neuron.2025.09.010_bib9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s43440-020-00097-z","article-title":"Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials","volume":"72","author":"Kryst","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuron.2025.09.010_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine\u2019s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib12","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1111\/bcp.15374","article-title":"Ketamine treatment for refractory anxiety: A systematic review","volume":"88","author":"Tully","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuron.2025.09.010_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/HRP.0000000000000330","article-title":"Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review","volume":"30","author":"Bandeira","year":"2022","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/20451253231154125","article-title":"The potential of ketamine for posttraumatic stress disorder: a review of clinical evidence","volume":"13","author":"Ragnhildstveit","year":"2023","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.neuron.2025.09.010_bib15","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2305772120","article-title":"Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments","volume":"120","author":"Krystal","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2025.09.010_bib16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.molmed.2023.02.003","article-title":"Bridging rapid and sustained antidepressant effects of ketamine","volume":"29","author":"Kim","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuron.2025.09.010_bib17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuron.2025.09.010_bib18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41398-020-00897-0","article-title":"A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression","volume":"10","author":"Shiroma","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","article-title":"Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression","volume":"67","author":"Aan Het Rot","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102127","article-title":"Ketamine for the treatment of major depression: a systematic review and meta-analysis","volume":"62","author":"Nikolin","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.neuron.2025.09.010_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1176\/appi.ajp.2018.18070834","article-title":"Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial","volume":"176","author":"Phillips","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpsychires.2018.09.013","article-title":"Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression","volume":"106","author":"Zheng","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuron.2025.09.010_bib23","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jpsychires.2021.11.006","article-title":"Is one or two infusions better in the first week of low-dose ketamine treatment for medication-resistant depression? A post hoc pooled analysis of randomized placebo-controlled and open-label trials","volume":"144","author":"Chen","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuron.2025.09.010_bib24","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41380-023-02397-1","article-title":"Targeting metaplasticity mechanisms to promote sustained antidepressant actions","volume":"29","author":"Brown","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib25","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.neubiorev.2011.12.011","article-title":"NMDA receptors and metaplasticity: mechanisms and possible roles in neuropsychiatric disorders","volume":"36","author":"Zorumski","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuron.2025.09.010_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1570159X14666160202121111","article-title":"Synaptic Plasticity, Metaplasticity and Depression","volume":"15","author":"Vose","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuron.2025.09.010_bib27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41398-024-03180-8","article-title":"Personalized use of ketamine and esketamine for treatment-resistant depression","volume":"14","author":"Medeiros","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib28","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1038\/s41380-022-01652-1","article-title":"Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis","volume":"27","author":"Medeiros","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib29","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S2215-0366(23)00183-9","article-title":"Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies","volume":"10","author":"Medeiros","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1176\/appi.ajp.20240515","article-title":"Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis","volume":"182","author":"Fountoulakis","year":"2025","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib31","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3390\/jcm11040938","article-title":"Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis","volume":"11","author":"Yu","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuron.2025.09.010_bib32","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.medj.2024.01.005","article-title":"Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin","volume":"5","author":"Rosenblat","year":"2024","journal-title":"Med."},{"key":"10.1016\/j.neuron.2025.09.010_bib33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/ph18020157","article-title":"Demystifying the Antidepressant Mechanism of Action of Stinels, a Novel Class of Neuroplastogens: Positive Allosteric Modulators of the NMDA Receptor","volume":"18","author":"Donello","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.neuron.2025.09.010_bib34","series-title":"The Organization of Behavior: A Neuropsychological Theory","author":"Hebb","year":"1949"},{"key":"10.1016\/j.neuron.2025.09.010_bib35","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1126\/science.1128134","article-title":"Learning induces long-term potentiation in the hippocampus","volume":"313","author":"Whitlock","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neuron.2025.09.010_bib36","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2023.0218","article-title":"Long-term potentiation: 50 years on: past, present and future","volume":"379","author":"Abraham","year":"2024","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuron.2025.09.010_bib37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrn2356","article-title":"Metaplasticity: tuning synapses and networks for plasticity","volume":"9","author":"Abraham","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.neuron.2016.12.015","article-title":"A Brief History of Long-Term Potentiation","volume":"93","author":"Nicoll","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2025.09.010_bib39","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nature13294","article-title":"Engineering a memory with LTD and LTP","volume":"511","author":"Nabavi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.09.010_bib40","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2023.0229","article-title":"Interplay of hippocampal long-term potentiation and long-term depression in enabling memory representations","volume":"379","author":"Hagena","year":"2024","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuron.2025.09.010_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2023.102815","article-title":"Mechanisms of NMDA receptor regulation","volume":"83","author":"Mony","year":"2023","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuron.2025.09.010_bib42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/309261a0","article-title":"Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones","volume":"309","author":"Mayer","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.09.010_bib43","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005710","article-title":"NMDA receptor-dependent long-term potentiation and long-term depression (LTP\/LTD)","volume":"4","author":"L\u00fcscher","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.neuron.2025.09.010_bib44","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-physiol-021014-071753","article-title":"Long-Term Potentiation: From CaMKII to AMPA Receptor Trafficking","volume":"78","author":"Herring","year":"2016","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.neuron.2025.09.010_bib45","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2023.0220","article-title":"Activity-dependent diffusion trapping of AMPA receptors as a key step for expression of early LTP","volume":"379","author":"Nowacka","year":"2024","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuron.2025.09.010_bib46","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.nlm.2007.10.001","article-title":"LTP maintenance and its protein synthesis-dependence","volume":"89","author":"Abraham","year":"2008","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuron.2025.09.010_bib47","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrn2867","article-title":"Long-term depression in the CNS","volume":"11","author":"Collingridge","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib48","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.neuron.2004.11.011","article-title":"Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses","volume":"44","author":"Zhou","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2025.09.010_bib49","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2023.0224","article-title":"Synapse-specific structural plasticity that protects and refines local circuits during LTP and LTD","volume":"379","author":"Harris","year":"2024","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuron.2025.09.010_bib57","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrn3353","article-title":"The BCM theory of synapse modification at 30: interaction of theory with experiment","volume":"13","author":"Cooper","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib58","doi-asserted-by":"crossref","first-page":"10924","DOI":"10.1073\/pnas.181342098","article-title":"Heterosynaptic metaplasticity in the hippocampus in vivo: a BCM-like modifiable threshold for LTP","volume":"98","author":"Abraham","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2025.09.010_bib59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fnbeh.2012.00085","article-title":"Brief environmental enrichment elicits metaplasticity of hippocampal synaptic potentiation in vivo","volume":"6","author":"Buschler","year":"2012","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib50","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/da.22738","article-title":"Impaired neuroplasticity in the prefrontal cortex in depression indexed through paired associative stimulation","volume":"35","author":"Noda","year":"2018","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.neuron.2025.09.010_bib51","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/npp.2015.310","article-title":"State-dependent partial occlusion of cortical LTP-like plasticity in major depression","volume":"41","author":"Kuhn","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2025.09.010_bib52","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1038\/npp.2013.126","article-title":"Neuroplasticity in depressed individuals compared with healthy controls","volume":"38","author":"Player","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2025.09.010_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108268","article-title":"Impaired LTD-like motor cortical plasticity in female patients with major depression disorder","volume":"179","author":"Yu","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuron.2025.09.010_bib54","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.biopsych.2006.10.006","article-title":"Long-term plasticity of visually evoked potentials in humans is altered in major depression","volume":"62","author":"Normann","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib55","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fnhum.2019.00072","article-title":"Impaired Modulation of Corticospinal Excitability in Drug-Free Patients With Major Depressive Disorder: A Theta-Burst Stimulation Study","volume":"13","author":"Vignaud","year":"2019","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib56","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.clinph.2021.04.002","article-title":"D-cycloserine normalizes long-term motor plasticity after transcranial magnetic intermittent theta-burst stimulation in major depressive disorder","volume":"132","author":"Cole","year":"2021","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neuron.2025.09.010_bib60","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1126\/science.1346729","article-title":"The influence of prior synaptic activity on the induction of long-term potentiation","volume":"255","author":"Huang","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuron.2025.09.010_bib61","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1523\/JNEUROSCI.18-03-00887.1998","article-title":"Primed facilitation of homosynaptic long-term depression and depotentiation in rat hippocampus","volume":"18","author":"Holland","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib62","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tins.2013.03.007","article-title":"Emerging roles of metaplasticity in behaviour and disease","volume":"36","author":"Hulme","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib63","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1007\/s00221-022-06486-5","article-title":"Epileptiform activity induced metaplasticity impairs bidirectional plasticity in the hippocampal CA1 synapses via GluN2B NMDA receptors","volume":"240","author":"Nasarudeen","year":"2022","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuron.2025.09.010_bib64","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1038\/sj.mp.4001016","article-title":"Synaptic plasticity and mood disorders","volume":"7","author":"Duman","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib65","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/sj.mp.4000811","article-title":"Neuroplasticity and cellular resilience in mood disorders","volume":"5","author":"Manji","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib66","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev-neuro-110920-040422","article-title":"Synaptic Mechanisms Regulating Mood State Transitions in Depression","volume":"45","author":"Parekh","year":"2022","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib67","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1038\/s41380-024-02625-2","article-title":"Beyond the serotonin deficit hypothesis: communicating a neuroplasticity framework of major depressive disorder","volume":"29","author":"Page","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib68","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.1503\/jpn.230090","article-title":"Pharmacological adjuncts and transcranial magnetic stimulation-induced synaptic plasticity: a systematic review","volume":"49","author":"Sohn","year":"2024","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib69","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/03036758.2020.1780274","article-title":"Human EEG and the mechanisms of memory: investigating long-term potentiation (LTP) in sensory-evoked potentials","volume":"51","author":"Kirk","year":"2021","journal-title":"J. R. Soc. N. Z."},{"key":"10.1016\/j.neuron.2025.09.010_bib70","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1113\/jphysiol.2002.023317","article-title":"Mechanisms of enhancement of human motor cortex excitability induced by interventional paired associative stimulation","volume":"543","author":"Stefan","year":"2002","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuron.2025.09.010_bib71","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neuron.2020.05.015","article-title":"Targeting Homeostatic Synaptic Plasticity for Treatment of Mood Disorders","volume":"106","author":"Kavalali","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2025.09.010_bib72","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","article-title":"Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics","volume":"42","author":"Aleksandrova","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuron.2025.09.010_bib73","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41386-022-01422-1","article-title":"Plasticity of synapses and reward circuit function in the genesis and treatment of depression","volume":"48","author":"Thompson","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2025.09.010_bib74","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.drudis.2009.05.002","article-title":"Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia","volume":"14","author":"Krystal","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuron.2025.09.010_bib75","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib76","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/s41386-018-0136-3","article-title":"The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects","volume":"43","author":"Abdallah","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2025.09.010_bib77","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/mp.2017.58","article-title":"Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression","volume":"23","author":"Esterlis","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib78","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/mp.2015.176","article-title":"Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine","volume":"21","author":"Carreno","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib79","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature25509","article-title":"Ketamine blocks bursting in the lateral habenula to rapidly relieve depression","volume":"554","author":"Yang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.09.010_bib80","doi-asserted-by":"crossref","first-page":"11","DOI":"10.31887\/DCNS.2014.16.1\/rduman","article-title":"Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections","volume":"16","author":"Duman","year":"2014","journal-title":"Dial. Clin. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib81","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41386-022-01411-4","article-title":"Rapid homeostatic plasticity and neuropsychiatric therapeutics","volume":"48","author":"Kavalali","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2025.09.010_bib82","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41586-023-06624-1","article-title":"Sustained antidepressant effect of ketamine through NMDAR trapping in the LHb","volume":"622","author":"Ma","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.09.010_bib83","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41386-023-01632-1","article-title":"Ketamine in neuropsychiatric disorders: an update","volume":"49","author":"Johnston","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2025.09.010_bib84","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41380-021-01121-1","article-title":"Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor","volume":"27","author":"Wei","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib85","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1176\/appi.ajp.163.1.153","article-title":"A double-blind, placebo-controlled study of memantine in the treatment of major depression","volume":"163","author":"Zarate","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib86","doi-asserted-by":"crossref","first-page":"966","DOI":"10.4088\/JCP.12m08252","article-title":"Antidepressant augmentation using the N-methyl-D-aspartate antagonist memantine: a randomized, double-blind, placebo-controlled trial","volume":"74","author":"Smith","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib87","first-page":"525","article-title":"Memantine add on to citalopram in elderly patients with depression: A double-blind placebo-controlled study","volume":"19","author":"Omranifard","year":"2014","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.neuron.2025.09.010_bib88","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.biopsych.2012.10.019","article-title":"A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression","volume":"74","author":"Zarate","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib89","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/npp.2016.224","article-title":"Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study","volume":"42","author":"Sanacora","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2025.09.010_bib90","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/mp.2013.130","article-title":"Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects","volume":"19","author":"Sanacora","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib91","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/JCP.0b013e31825d70d6","article-title":"A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder","volume":"32","author":"Ibrahim","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuron.2025.09.010_bib92","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/JCP.0b013e31818a6cea","article-title":"An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder","volume":"28","author":"Preskorn","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuron.2025.09.010_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2016.01.016","article-title":"Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders","volume":"159","author":"Nguyen","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuron.2025.09.010_bib94","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21m14345","article-title":"Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients With Major Depressive Disorder: A Phase 3 Randomized Clinical Trial (GEMINI)","volume":"83","author":"Iosifescu","year":"2022","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib95","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1176\/appi.ajp.21080800","article-title":"Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial","volume":"179","author":"Tabuteau","year":"2022","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib96","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1176\/appi.ajp.20220434","article-title":"Understanding the Efficacy and Mechanism of Action of a Dextromethorphan-Bupropion Combination: Where Does It Fit in the NMDA Versus mu-Opioid Story?","volume":"179","author":"Schatzberg","year":"2022","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib97","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.09.010_bib98","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41386-025-02085-4","article-title":"Rapid hippocampal synaptic potentiation induced by ketamine metabolite (2R,6R)-hydroxynorketamine persistently primes synaptic plasticity","volume":"50","author":"Brown","year":"2025","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2025.09.010_bib99","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1523\/JNEUROSCI.1316-22.2022","article-title":"NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine","volume":"43","author":"Zanos","year":"2023","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib100","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1073\/pnas.1816071116","article-title":"Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function","volume":"116","author":"Lumsden","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2025.09.010_bib101","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41386-019-0443-3","article-title":"(2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanism","volume":"45","author":"Riggs","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2025.09.010_bib102","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/cpt.3391","article-title":"A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy Volunteers","volume":"116","author":"Raja","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuron.2025.09.010_bib103","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1176\/appi.ajp.2018.17060720","article-title":"Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study","volume":"175","author":"Canuso","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib104","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m13191","article-title":"Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I)","volume":"81","author":"Fu","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/ijnp\/pyaa068","article-title":"Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)","volume":"24","author":"Ionescu","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuron.2025.09.010_bib106","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF01061410","article-title":"Dose-finding studies in clinical drug development","volume":"34","author":"Schmidt","year":"1988","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuron.2025.09.010_bib107","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev-clinpsy-072120-014126","article-title":"Ketamine and the Future of Rapid-Acting Antidepressants","volume":"17","author":"Riggs","year":"2021","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.neuron.2025.09.010_bib108","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41593-021-00868-8","article-title":"Sustained effects of rapidly acting antidepressants require BDNF-dependent MeCP2 phosphorylation","volume":"24","author":"Kim","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib109","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8078","article-title":"Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation","volume":"364","author":"Moda-Sava","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.neuron.2025.09.010_bib110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41583-024-00876-0","article-title":"Structural neural plasticity evoked by rapid-acting antidepressant interventions","volume":"26","author":"Liao","year":"2025","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib111","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41398-018-0321-5","article-title":"Ketamine and selective activation of parvalbumin interneurons inhibit stress-induced dendritic spine elimination","volume":"8","author":"Ng","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-24933-8","article-title":"Longitudinal two-photon imaging in somatosensory cortex of behaving mice reveals dendritic spine formation enhancement by subchronic administration of low-dose ketamine","volume":"8","author":"Pryazhnikov","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuron.2025.09.010_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.659052","article-title":"Repeated Dosing of Ketamine in the Forced Swim Test: Are Multiple Shots Better Than One?","volume":"12","author":"Weston","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib114","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00018-024-05121-6","article-title":"Ketamine\u2019s rapid and sustained antidepressant effects are driven by distinct mechanisms","volume":"81","author":"Rawat","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuron.2025.09.010_bib115","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1192\/bjp.bp.116.195826","article-title":"Adjunctive ketamine in electroconvulsive therapy: updated systematic review and meta-analysis","volume":"210","author":"McGirr","year":"2017","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib116","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000517074","article-title":"Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical Trial","volume":"90","author":"Wilkinson","year":"2021","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.neuron.2025.09.010_bib117","first-page":"45","article-title":"Ketamine Enhances Visual Sensory Evoked Potential Long-term Potentiation in Patients With Major Depressive Disorder","volume":"5","author":"Sumner","year":"2020","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.neuron.2025.09.010_bib118","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1098\/rstb.2008.0198","article-title":"Bidirectional synaptic mechanisms of ocular dominance plasticity in visual cortex","volume":"364","author":"Smith","year":"2009","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuron.2025.09.010_bib119","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.biopsych.2024.06.021","article-title":"Fluoxetine and Ketamine Enhance Extinction Memory and Brain Plasticity by Triggering the p75 Neurotrophin Receptor Proteolytic Pathway","volume":"97","author":"Diniz","year":"2025","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib120","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/ejn.15929","article-title":"Ketamine and its metabolite 2R,6R-hydroxynorketamine promote ocular dominance plasticity and release tropomyosin-related kinase B from inhibitory control without reducing perineuronal nets enwrapping parvalbumin interneurons","volume":"57","author":"Cannarozzo","year":"2023","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib121","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.brainres.2015.03.019","article-title":"Effect of acute NR2B antagonist treatment on long-term potentiation in the rat hippocampus","volume":"1609","author":"Graef","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.neuron.2025.09.010_bib122","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/npp.2012.246","article-title":"GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects","volume":"38","author":"Burgdorf","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2025.09.010_bib123","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fnsyn.2018.00008","article-title":"Intravascular Ketamine Increases Theta-Burst but Not High Frequency Tetanus Induced LTP at CA3-CA1 Synapses Within Three Hours and Devoid of an Increase in Spine Density","volume":"10","author":"Widman","year":"2018","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib124","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fnbeh.2018.00229","article-title":"Effect of Ketamine on LTP and NMDAR EPSC in Hippocampus of the Chronic Social Defeat Stress Mice Model of Depression","volume":"12","author":"Yang","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13041-020-00627-z","article-title":"Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression","volume":"13","author":"Aleksandrova","year":"2020","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuron.2025.09.010_bib126","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.biopsych.2014.04.014","article-title":"Restoring mood balance in depression: ketamine reverses deficit in dopamine-dependent synaptic plasticity","volume":"76","author":"Belujon","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib127","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1038\/mp.2017.239","article-title":"Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit","volume":"23","author":"Yao","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib128","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.neuropharm.2008.07.046","article-title":"Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticity","volume":"55","author":"Yashiro","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuron.2025.09.010_bib129","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1101\/lm.039222.115","article-title":"Norepinephrine triggers metaplasticity of LTP by increasing translation of specific mRNAs","volume":"22","author":"Maity","year":"2015","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuron.2025.09.010_bib130","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/hipo.22250","article-title":"Cocaine- or stress-induced metaplasticity of LTP in the dorsal and ventral hippocampus","volume":"24","author":"Keralapurath","year":"2014","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuron.2025.09.010_bib131","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/ijnp\/pyab010","article-title":"Repeated but not single administration of ketamine prolongs increases of the firing activity of norepinephrine and dopamine neurons","volume":"24","author":"Iro","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuron.2025.09.010_bib132","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","article-title":"Antidepressant drugs act by directly binding to TRKB neurotrophin receptors","volume":"184","author":"Casarotto","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2025.09.010_bib133","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib134","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.tins.2024.08.011","article-title":"Rethinking the role of TRKB in the action of antidepressants and psychedelics","volume":"47","author":"Brunello","year":"2024","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib135","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.adf0435","article-title":"Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors","volume":"379","author":"Vargas","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.neuron.2025.09.010_bib136","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1126\/science.adg2989","article-title":"Possible psychedelic therapeutic mechanism","volume":"379","author":"Hess","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.neuron.2025.09.010_bib137","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41586-023-06204-3","article-title":"Psychedelics reopen the social reward learning critical period","volume":"618","author":"Nardou","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.09.010_bib138","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev-pharmtox-061724-080548","article-title":"Targeting Neuroplasticity in Substance Use Disorders: Implications for Therapeutics","volume":"65","author":"Wolf","year":"2025","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuron.2025.09.010_bib139","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1176\/appi.ajp.20240378","article-title":"Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions?","volume":"182","author":"Levinstein","year":"2025","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib140","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s00213-022-06118-4","article-title":"Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors","volume":"239","author":"Wulf","year":"2022","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.neuron.2025.09.010_bib141","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1073\/pnas.1916570117","article-title":"Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents","volume":"117","author":"Klein","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2025.09.010_bib142","doi-asserted-by":"crossref","first-page":"34","DOI":"10.18433\/J3GP53","article-title":"Understanding the hysteresis loop conundrum in pharmacokinetic\/pharmacodynamic relationships","volume":"17","author":"Louizos","year":"2014","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.neuron.2025.09.010_bib143","first-page":"508","article-title":"Die dritte Defension wegen des Schreibens der neuen Rezepte","volume":"1538","author":"Paracelsus","year":"1965","journal-title":"Septem Defensiones."},{"key":"10.1016\/j.neuron.2025.09.010_bib144","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jad.2024.03.137","article-title":"Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for Major depression: A systematic review and meta-analysis","volume":"356","author":"Seshadri","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuron.2025.09.010_bib146","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1192\/bjp.147.6.593","article-title":"The importance of dosage in prescribing antidepressants","volume":"147","author":"Quitkin","year":"1985","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib147","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib148","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-20190-4","article-title":"The role of dissociation in ketamine\u2019s antidepressant effects","volume":"11","author":"Ballard","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuron.2025.09.010_bib149","doi-asserted-by":"crossref","first-page":"e852","DOI":"10.4088\/JCP.17f11738","article-title":"Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency?","volume":"78","author":"Andrade","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib150","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib151","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00406-024-01925-6","article-title":"Ketamine-induced altered states of consciousness: a systematic review of implications for therapeutic outcomes in psychiatric practices","volume":"275","author":"da Costa Goncalves","year":"2025","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112378","article-title":"Increasing doses of ketamine curtail antidepressant responses and suppress associated synaptic signaling pathways","volume":"380","author":"Kim","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuron.2025.09.010_bib153","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.biopsych.2022.06.016","article-title":"Nitrous Oxide, a Rapid Antidepressant, Has Ketamine-like Effects on Excitatory Transmission in the Adult Hippocampus","volume":"92","author":"Izumi","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib154","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.neuropharm.2014.08.002","article-title":"Metaplastic effects of subanesthetic ketamine on CA1 hippocampal function","volume":"86","author":"Izumi","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuron.2025.09.010_bib155","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/laban.571","article-title":"Hippocampal long-term potentiation in adult mice after recovery from ketamine anesthesia","volume":"43","author":"Ribeiro","year":"2014","journal-title":"Lab Anim. (NY)"},{"key":"10.1016\/j.neuron.2025.09.010_bib156","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1098-1063(1997)7:2<137::AID-HIPO3>3.0.CO;2-K","article-title":"Induction and reversal of long-term potentiation by repeated high-frequency stimulation in rat hippocampal slices","volume":"7","author":"Abraham","year":"1997","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuron.2025.09.010_bib157","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1073\/pnas.1120700109","article-title":"Synaptic evidence for the efficacy of spaced learning","volume":"109","author":"Kram\u00e1r","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2025.09.010_bib158","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1523\/JNEUROSCI.19-19-08712.1999","article-title":"Time-dependent reversal of long-term potentiation in area CA1 of the freely moving rat induced by theta pulse stimulation","volume":"19","author":"St\u00e4ubli","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib159","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1152\/jn.1997.77.2.571","article-title":"Heterosynaptic LTD and depotentiation in the medial perforant path of the dentate gyrus in the freely moving rat","volume":"77","author":"Doy\u00e8re","year":"1997","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuron.2025.09.010_bib160","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1152\/jn.00297.2014","article-title":"Augmenting saturated LTP by broadly spaced episodes of theta-burst stimulation in hippocampal area CA1 of adult rats and mice","volume":"112","author":"Cao","year":"2014","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuron.2025.09.010_bib161","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0306-4522(95)00117-2","article-title":"Asymptotic hippocampal long-term potentiation in rats does not preclude additional potentiation at later phases","volume":"67","author":"Frey","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuron.2025.09.010_bib162","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0166-2236(97)01189-2","article-title":"Synaptic tagging: implications for late maintenance of hippocampal long-term potentiation","volume":"21","author":"Frey","year":"1998","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib163","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression","volume":"173","author":"Singh","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib164","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S2215-0366(22)00317-0","article-title":"Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability","volume":"9","author":"Smith-Apeldoorn","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib165","series-title":"Spravato (Esketamine) [Drug Label]","year":"2019"},{"key":"10.1016\/j.neuron.2025.09.010_bib166","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.09.010_bib167","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib168","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1523\/JNEUROSCI.02-01-00032.1982","article-title":"Theory for the development of neuron selectivity: orientation specificity and binocular interaction in visual cortex","volume":"2","author":"Bienenstock","year":"1982","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib169","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1098\/rstb.2002.1255","article-title":"Bidirectional synaptic plasticity: from theory to reality","volume":"358","author":"Bear","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuron.2025.09.010_bib170","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41386-018-0096-7","article-title":"Metaplasticity contributes to memory formation in the hippocampus","volume":"44","author":"Crestani","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2025.09.010_bib171","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/nn1965","article-title":"Experience-dependent recovery of vision following chronic deprivation amblyopia","volume":"10","author":"He","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib172","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nn.2250","article-title":"N-Acetylcysteine reverses cocaine-induced metaplasticity","volume":"12","author":"Moussawi","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib173","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2217\/fnl.09.62","article-title":"Promoting neurological recovery of function via metaplasticity","volume":"5","author":"Cho","year":"2010","journal-title":"Future Neurol."},{"key":"10.1016\/j.neuron.2025.09.010_bib174","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.biopsych.2021.05.023","article-title":"The neurobiological effects of electroconvulsive therapy studied through magnetic resonance: what have we learned, and where do we go?","volume":"91","author":"Ousdal","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib175","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.clinph.2010.08.016","article-title":"The theoretical model of theta burst form of repetitive transcranial magnetic stimulation","volume":"122","author":"Huang","year":"2011","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neuron.2025.09.010_bib176","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00221-010-2293-4","article-title":"Simply longer is not better: reversal of theta burst after-effect with prolonged stimulation","volume":"204","author":"Gamboa","year":"2010","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuron.2025.09.010_bib177","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1113\/jphysiol.2008.152793","article-title":"Bidirectional long-term motor cortical plasticity and metaplasticity induced by quadripulse transcranial magnetic stimulation","volume":"586","author":"Hamada","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuron.2025.09.010_bib178","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.brs.2015.03.004","article-title":"Efficacy and Time Course of Theta Burst Stimulation in Healthy Humans","volume":"8","author":"Wischnewski","year":"2015","journal-title":"Brain Stimul."},{"key":"10.1016\/j.neuron.2025.09.010_bib179","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1176\/appi.ajp.2021.20101429","article-title":"Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial","volume":"179","author":"Cole","year":"2022","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib180","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jad.2014.10.068","article-title":"Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial","volume":"173","author":"McGirr","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuron.2025.09.010_bib181","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41591-022-02197-0","article-title":"New and emerging approaches to treat psychiatric disorders","volume":"29","author":"Scangos","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuron.2025.09.010_bib182","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/jamapsychiatry.2022.3255","article-title":"Efficacy of Adjunctive D-Cycloserine to Intermittent Theta-Burst Stimulation for Major Depressive Disorder: A Randomized Clinical Trial","volume":"79","author":"Cole","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib183","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2013.06.059","article-title":"Stress-induced metaplasticity: from synapses to behavior","volume":"250","author":"Schmidt","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuron.2025.09.010_bib184","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/10253890.2017.1301424","article-title":"Academic stress disrupts cortical plasticity in graduate students","volume":"20","author":"Concerto","year":"2017","journal-title":"Stress"},{"key":"10.1016\/j.neuron.2025.09.010_bib185","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1523\/JNEUROSCI.1963-08.2008","article-title":"Cortisol inhibits neuroplasticity induction in human motor cortex","volume":"28","author":"Sale","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib186","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nrn2639","article-title":"Effects of stress throughout the lifespan on the brain, behaviour and cognition","volume":"10","author":"Lupien","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib187","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1523\/JNEUROSCI.0733-19.2019","article-title":"Revisiting the Stress Concept: Implications for Affective Disorders","volume":"40","author":"McEwen","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib188","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1100\/tsw.2010.48","article-title":"Corticosteroid regulation of synaptic plasticity in the hippocampus","volume":"10","author":"Maggio","year":"2010","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.neuron.2025.09.010_bib189","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1523\/JNEUROSCI.0155-07.2007","article-title":"Striking variations in corticosteroid modulation of long-term potentiation along the septotemporal axis of the hippocampus","volume":"27","author":"Maggio","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib190","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hipo.20751","article-title":"Stress-induced dynamic routing of hippocampal connectivity: a hypothesis","volume":"20","author":"Segal","year":"2010","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuron.2025.09.010_bib191","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/abbs\/36.5.375","article-title":"Effects of chronic stress and phenytoin on the long-term potentiation (LTP) in rat hippocampal CA1 region","volume":"36","author":"Zheng","year":"2004","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.neuron.2025.09.010_bib192","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1046\/j.1460-9568.2003.02622.x","article-title":"Chronic unpredictable stress impairs long-term potentiation in rat hippocampal CA1 area and dentate gyrus in vitro","volume":"17","author":"Alfarez","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib193","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.nlm.2018.01.008","article-title":"Running exercise mitigates the negative consequences of chronic stress on dorsal hippocampal long-term potentiation in male mice","volume":"149","author":"Miller","year":"2018","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuron.2025.09.010_bib194","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41398-025-03246-1","article-title":"A network-based analysis anticipates time to recovery from major depression revealing a plasticity by context interplay","volume":"15","author":"Delli Colli","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuropharm.2018.04.007","article-title":"Environmental enrichment effects on synaptic and cellular physiology of hippocampal neurons","volume":"145","author":"Ohline","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuron.2025.09.010_bib196","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbr.2015.05.032","article-title":"Environmental enrichment modulates intrinsic cellular excitability of hippocampal CA1 pyramidal cells in a housing duration and anatomical location-dependent manner","volume":"292","author":"Valero-Aracama","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuron.2025.09.010_bib197","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/7854_2010_108","article-title":"Animal models of depression: molecular perspectives","volume":"7","author":"Krishnan","year":"2011","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib198","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12264-024-01270-7","article-title":"Behavioral Animal Models and Neural-Circuit Framework of Depressive Disorder","volume":"41","author":"Tian","year":"2025","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neuron.2025.09.010_bib199","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/B978-0-444-52002-9.00009-7","article-title":"Animal models of psychiatric disorders","volume":"106","author":"Koob","year":"2012","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.neuron.2025.09.010_bib200","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/s41593-022-01146-x","article-title":"Experimenters\u2019 sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor","volume":"25","author":"Georgiou","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib201","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-024-07624-5","article-title":"Psilocybin desynchronizes the human brain","volume":"632","author":"Siegel","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.09.010_bib202","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1176\/appi.ajp.20230172","article-title":"Psychedelics as Transformative Therapeutics","volume":"180","author":"Roth","year":"2023","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib203","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2025.09.010_bib204","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41586-025-08813-6","article-title":"Psilocybin\u2019s lasting action requires pyramidal cell types and 5-HT2A receptors","volume":"642","author":"Shao","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2025.09.010_bib205","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1416420","article-title":"Psilocybin for major depressive disorder: a systematic review of randomized controlled studies","volume":"15","author":"Li","year":"2024","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib206","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0269881118754710","article-title":"Psychedelics and the essential importance of context","volume":"32","author":"Carhart-Harris","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuron.2025.09.010_bib207","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00005053-196312000-00007","article-title":"Reactions to psilocybjn administered in a supportive environment","volume":"137","author":"Leary","year":"1963","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.neuron.2025.09.010_bib208","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S2215-0366(23)00363-2","article-title":"Treatment with psychedelics is psychotherapy: beyond reductionism","volume":"11","author":"Gr\u00fcnder","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib209","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0269881117731279","article-title":"Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors","volume":"32","author":"Griffiths","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuron.2025.09.010_bib210","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","article-title":"The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future","volume":"42","author":"Carhart-Harris","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2025.09.010_bib211","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.psyneuen.2010.08.011","article-title":"The double edged sword of neural plasticity: increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover","volume":"36","author":"Branchi","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuron.2025.09.010_bib212","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/neuro.08.003.2007","article-title":"Polymorphism of the 5-HT2A receptor gene: Association with stress-related indices in healthy middle-aged adults","volume":"1","author":"Fiocco","year":"2007","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuron.2025.09.010_bib213","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/archpsyc.64.3.356","article-title":"Serotonin receptor 2A gene and the influence of childhood maternal nurturance on adulthood depressive symptoms","volume":"64","author":"Jokela","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib214","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpsychires.2024.05.051","article-title":"Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review","volume":"176","author":"Chisamore","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuron.2025.09.010_bib215","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/s41386-023-01613-4","article-title":"UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice","volume":"48","author":"Rijsketic","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2025.09.010_bib216","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11731","article-title":"Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital","volume":"79","author":"Wilkinson","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib217","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jad.2020.07.089","article-title":"Long-term outcome in outpatients with depression treated with acute and maintenance intravenous ketamine: A retrospective chart review","volume":"276","author":"Sakurai","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuron.2025.09.010_bib218","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jamapsychiatry.2024.4787","article-title":"Strengthening Safeguards for Psychiatric Uses of Ketamine","volume":"82","author":"Barnett","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib219","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jamapsychiatry.2023.4945","article-title":"The Rapidly Shifting Ketamine Landscape in the US","volume":"81","author":"Wilkinson","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neuron.2025.09.010_bib220","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/d41586-019-02133-2","article-title":"Depression researchers rethink popular mouse swim tests","volume":"571","author":"Reardon","year":"2019","journal-title":"Nature"}],"container-title":["Neuron"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896627325006981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896627325006981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:37:46Z","timestamp":1773808666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896627325006981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":220,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0896627325006981"],"URL":"https:\/\/doi.org\/10.1016\/j.neuron.2025.09.010","relation":{},"ISSN":["0896-6273"],"issn-type":[{"value":"0896-6273","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synaptic priming: A framework for pharmacotherapy in depression","name":"articletitle","label":"Article Title"},{"value":"Neuron","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuron.2025.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}